Posts Tagged ‘HVTN 505’

April 29th, 2013

Data Safety Monitoring Board Closes HIV Vaccine Study — the End of Adenovirus as a Vaccine Vector?

On Friday, the NIH announced that HVTN 505, a clinical trial of an HIV vaccine using an adenovirus vector, would be stopped based on a finding of futility by an independent DSMB. The study had enrolled some 2500 high-risk gay men in the United States. Here are the three key findings leading to this action: New infections in […]


HIV Information: Author Paul Sax, M.D.

Paul E. Sax, MD

Contributing Editor

NEJM Journal Watch
Infectious Diseases

Biography | Disclosures | Summaries

Learn more about HIV and ID Observations.